Contact Us
Artificial Intelligence (AI) In Clinical Trials Global Market Report 2025
Global Artificial Intelligence (AI) In Clinical Trials Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Artificial Intelligence (AI) In Clinical Trials Global Market Report 2025

By Offering (Software, Services), By Process (Trial Design, Patient Selection, Site Selection, Patient Monitoring), By Application (Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications), By End-User (Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Artificial Intelligence (AI) In Clinical Trials Market Overview

• Artificial Intelligence (AI) In Clinical Trials market size has reached to $7.19 billion in 2024

• Expected to grow to $36.12 billion in 2029 at a compound annual growth rate (CAGR) of 37.5%

• Growth Driver: Ai's Crucial Role In Reducing Clinical Trial Expenditure Fuels The Artificial Intelligence In The Clinical Trial Market Growth

• Market Trend: Innovative Products Reshapes The Artificial Intelligence In The Clinical Trial Market

North America was the largest region and fastest growing region.

What Is Covered Under Artificial Intelligence (AI) In Clinical Trials Market?

Artificial intelligence in clinical trials refers to using artificial intelligence to design more efficient and adequate clinical trials. Artificial intelligence is used in clinical trials to improve trial design and optimization through predictions about patient behavior and drug efficacy.

The main offerings of artificial intelligence (AI) in clinical trials are software and services. Software solutions refer to a type of custom-built or configured solution to solve a problem, and artificial intelligence software is used to enable faster and more accurate hypothesis generation and to understand the evolution of a disease. They are applied for various processes such as trial design, patient selection, site selection, and patient monitoring in Oncology, neurological diseases and conditions, cardiovascular diseases, metabolic diseases, infectious diseases, immunology diseases, and others. It is used by pharmaceutical and biotechnology companies, contract research organizations, and others.

Artificial Intelligence (AI) In Clinical Trials Market Size and growth rate 2025 to 2029: Graph

What Is The Artificial Intelligence (AI) In Clinical Trials Market Size 2025 And Growth Rate?

The artificial intelligence (AI) in clinical trials market size has grown exponentially in recent years. It will grow from $7.19 billion in 2024 to $10.11 billion in 2025 at a compound annual growth rate (CAGR) of 40.6%. The growth in the historic period can be attributed to increasing data complexity, rising costs and time constraints, regulatory demands, early AI applications, patient-centric approaches

What Is The Artificial Intelligence (AI) In Clinical Trials Market Growth Forecast?

The artificial intelligence (AI) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $36.12 billion in 2029 at a compound annual growth rate (CAGR) of 37.5%. The growth in the forecast period can be attributed to personalized medicine emphasis, real-time monitoring solutions, remote trial execution, risk prediction and mitigation, expanded data sources integration. Major trends in the forecast period include adaptive trial design, natural language processing (NLP) in data analysis, ai-driven patient recruitment, blockchain integration for data security, predictive analytics for patient outcomes.

The forecast of 37.5% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by delaying drug development due to restricted access to AI-based patient recruitment platforms hosted in Switzerland. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Information Technology Industry?

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the information technology sector, particularly in hardware manufacturing, data infrastructure, and software deployment. Higher duties on imported semiconductors, circuit boards, and networking equipment have raised production and operational costs for tech firms, cloud service providers, and data centers. Companies relying on globally sourced components for laptops, servers, and consumer electronics are facing longer lead times and increased pricing pressures. In parallel, tariffs on specialized software tools and retaliatory measures from key international markets have disrupted global IT supply chains and reduced overseas demand for U.S.-developed technologies. To navigate these challenges, the sector is accelerating investments in domestic chip fabrication, diversifying supplier bases, and adopting AI-driven automation to enhance operational resilience and cost efficiency.

How Is The Artificial Intelligence (AI) In Clinical Trials Market Segmented?

1) By Offering: Software, Services

2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring

3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users

Subsegments:

1) By Software: AI-driven Analytics Platforms, Data Management Tools, Patient Recruitment Solutions, Predictive Modeling Software

2) By Services: Consulting Services, Data Annotation And Labeling Services, Custom AI Model Development, Implementation And Integration Services

What Is Driving The Artificial Intelligence (AI) In Clinical Trials Market? Ai's Crucial Role In Reducing Clinical Trial Expenditure Fuels The Artificial Intelligence In The Clinical Trial Market Growth

The growing need to curb clinical trial costs is expected to propel the growth of artificial intelligence in the clinical trial market going forward. Clinical trials refer to research studies used to test medical, surgical, or behavioral intervention in people, and the costs of clinical trials include the cost of the research and the cost of patient care. Drug development and other clinical trial processes are costly by nature, and artificial intelligence is used to provide better drug discovery, better designed and safer clinical trials, and improved patient outcomes at lower costs. For instance, in February 2023, according to Genetic Engineering and Biotechnology News, a US-based platform that provides the latest information on genetic engineering and biotechnology, developing a new drug among the top 20 global biopharma companies rose by 15% from $298 million in 2022 to approximately $2.3 billion in 2023, and this includes the costs incurred from developing a drug through clinical trials. Furthermore, in January 2023, according to a report published by the National Bureau of Economic Research (NBER), a US-based non-profit economic research organization, the adoption of AI within the next five years is expected to generate substantial cost savings in healthcare, ranging from 5 to 10% of healthcare spending, equating to approximately $200 billion to $360 billion in annual savings. Therefore, the growing need to curb clinical trial costs will drive artificial intelligence in the clinical trial market.

What Is Driving The Artificial Intelligence (AI) In Clinical Trials Market? Surge In Research And Development Activities Propels The Growth Of Artificial Intelligence In The Clinical Trial Market

The increasing number of research and development activities is expected to propel the growth of artificial intelligence in the clinical trial market going forward. Research and Development (R&D) activities refer to the systematic process of investigation, experimentation, and innovation conducted by organizations or individuals to create new products, processes, or knowledge. Artificial Intelligence (AI) plays a significant role in enhancing various aspects of research and development (R&D) activities in the context of clinical trials such as analyzing diverse datasets, implementation of adaptive trial designs, streamlining administrative processes, and others. For instance, in May 2023, according to Xtalks, a Canada-based company providing digital media formats portfolio, the R&D pipeline for drugs saw an increase from 18,582 in 2021 to over 20,109 drugs in 2022. Additionally, in 2023, the global count of registered clinical trials has surged to 452,604, marking a substantial rise from the reported figure of over 365,000 trials in 2021. Therefore, the increasing number of research and development activities will drive artificial intelligence in the clinical trial market.

Who Are The Major Players In The Global Artificial Intelligence (AI) In Clinical Trials Market?

Major companies operating in the artificial intelligence (AI) in clinical trials market include Medable Inc., PathAI inc., Saama Technologies Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc.

What Are The Key Trends Of The Global Artificial Intelligence (AI) In Clinical Trials Market? Innovative Products Reshapes The Artificial Intelligence In The Clinical Trial Market

Innovative product offerings are a key trend in artificial intelligence in the clinical trial market. Major companies in the artificial intelligence in clinical trials market have introduced innovative product offerings to sustain their position in the market. For instance, in January 2023, Elligo Health Research Inc., a US-based healthcare-enabling research organization, launched DataAI Connect, an innovative data and technology platform that enables rapid, data-driven clinical research. The platform effortlessly gathers, manages, evaluates, and shares real-world patient data, presenting a comprehensive strategy to overcome clinical trial obstacles instead of acting as an accessory technology. This adaptable and sustainable platform includes an all-in-one solution for retrieving and evaluating medical records. It adeptly transforms data into practical insights and individual patient progress information, leveraging cutting-edge technologies such as NLP, ML, and clinical acumen.

What Are The Key Trends Of The Global Artificial Intelligence (AI) In Clinical Trials Market? Industry Players Embraces AI Feasibility And Recruitment Platforms To Redefine Artificial Intelligence In Clinical Trials Market

Major companies operating in the artificial intelligence in clinical trials market are focusing on development of innovative technologies such as AI feasibility and recruitment platforms. AI feasibility and recruitment platforms are tools or systems that leverage artificial intelligence (AI) to assess the viability and potential success of clinical trials while also assisting in the efficient recruitment of suitable participants. For instance, in June 2023, a US-based research provider company, announced the launch of ‘ObjectiveScreen’. It is an AI-powered feasibility and recruitment platform that enhances clinical trial performance and results by improving patient identification, prequalification, and retention processes. ObjectiveScreen enables direct connectivity between clinical trial sites and electronic health records (EHRs) of patients. The AI platform promotes patient engagement by simplifying and streamlining appointment scheduling and communication processes.

Need data on a specific region in this market?

Artificial Intelligence (AI) In Clinical Trials Market Merger And Acquisition: Paradigm Health Expands Horizons With Strategic Acquisition Of Deep Lens Inc

In January 2023, Paradigm Health Inc., a US-based healthcare technology company, acquired Deep Lens Inc. for an undisclosed amount. The acquisition aims to provide Paradigm with Deep Lens's platform, which enables equal access to trials for all patients while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. Deep Lens Inc. is a US-based provider of an AI-driven cloud platform for clinical research.

Regional Outlook For The Global Artificial Intelligence (AI) In Clinical Trials Market

North America was the largest region in the artificial intelligence (AI) in clinical trials market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Artificial Intelligence (AI) In Clinical Trials Market?

The artificial intelligence (AI) in clinical trials market consists of revenues earned by entities by providing artificial intelligence in clinical trials services that include data security and compliance services and consulting and implementation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the clinical trials market also includes sales of clinical trial matching software, patient recruitment software and medical image analysis software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Artificial Intelligence (AI) In Clinical Trials Industry?

The artificial intelligence (ai) in clinical trials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai) in clinical trials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Artificial Intelligence (AI) In Clinical Trials Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $10.11 billion
Revenue Forecast In 2034 $36.12 billion
Growth Rate CAGR of 37.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users Subsegments: 1) By Software: AI-driven Analytics Platforms, Data Management Tools, Patient Recruitment Solutions, Predictive Modeling Software
2) By Services: Consulting Services, Data Annotation And Labeling Services, Custom AI Model Development, Implementation And Integration Services
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Medable Inc., PathAI inc., Saama Technologies Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Artificial Intelligence (AI) In Clinical Trials Market Characteristics

3. Artificial Intelligence (AI) In Clinical Trials Market Trends And Strategies

4. Artificial Intelligence (AI) In Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI) In Clinical Trials Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence (AI) In Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Artificial Intelligence (AI) In Clinical Trials Market Growth Rate Analysis

5.4. Global Artificial Intelligence (AI) In Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Artificial Intelligence (AI) In Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Artificial Intelligence (AI) In Clinical Trials Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In Clinical Trials Market Segmentation

6.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Software

Services

6.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Trial Design

Patient Selection

Site Selection

Patient Monitoring

6.3. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Neurological Disease And Condition

Cardiovascular Disease

Metabolic Disease

Infectious Disease

Immunology Disease

Other Applications

6.4. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biotechnology Company

Contract Research Organizations

Other End-Users

6.5. Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

AI-driven Analytics Platforms

Data Management Tools

Patient Recruitment Solutions

Predictive Modeling Software

6.6. Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consulting Services

Data Annotation And Labeling Services

Custom AI Model Development

Implementation And Integration Services

7. Artificial Intelligence (AI) In Clinical Trials Market Regional And Country Analysis

7.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market

8.1. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In Clinical Trials Market

9.1. China Artificial Intelligence (AI) In Clinical Trials Market Overview

9.2. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In Clinical Trials Market

10.1. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In Clinical Trials Market

11.1. Japan Artificial Intelligence (AI) In Clinical Trials Market Overview

11.2. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In Clinical Trials Market

12.1. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In Clinical Trials Market

13.1. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In Clinical Trials Market

14.1. South Korea Artificial Intelligence (AI) In Clinical Trials Market Overview

14.2. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In Clinical Trials Market

15.1. Western Europe Artificial Intelligence (AI) In Clinical Trials Market Overview

15.2. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In Clinical Trials Market

16.1. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In Clinical Trials Market

17.1. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In Clinical Trials Market

18.1. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In Clinical Trials Market

19.1. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In Clinical Trials Market

20.1. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market

21.1. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market Overview

21.2. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In Clinical Trials Market

22.1. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In Clinical Trials Market

23.1. North America Artificial Intelligence (AI) In Clinical Trials Market Overview

23.2. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In Clinical Trials Market

24.1. USA Artificial Intelligence (AI) In Clinical Trials Market Overview

24.2. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In Clinical Trials Market

25.1. Canada Artificial Intelligence (AI) In Clinical Trials Market Overview

25.2. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In Clinical Trials Market

26.1. South America Artificial Intelligence (AI) In Clinical Trials Market Overview

26.2. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In Clinical Trials Market

27.1. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In Clinical Trials Market

28.1. Middle East Artificial Intelligence (AI) In Clinical Trials Market Overview

28.2. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In Clinical Trials Market

29.1. Africa Artificial Intelligence (AI) In Clinical Trials Market Overview

29.2. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In Clinical Trials Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence (AI) In Clinical Trials Market Competitive Landscape

30.2. Artificial Intelligence (AI) In Clinical Trials Market Company Profiles

30.2.1. Medable Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. PathAI inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Saama Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. TriNetX LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.5. SymphonyAI Summit Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In Clinical Trials Market Other Major And Innovative Companies

31.1. Aktana

31.2. Nference Inc.

31.3. Insilico Medicine Inc.

31.4. Vineti Inc.

31.5. Innoplexus AG

31.6. Healx

31.7. AiCure Inc.

31.8. MEDIAN Technologies SA

31.9. Owkin Inc.

31.10. Science 37

31.11. Ardigen SA

31.12. Cyft Inc.

31.13. Unlearn.AI Inc.

31.14. Mendel AI

31.15. Deep Lens Inc.

32. Global Artificial Intelligence (AI) In Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Clinical Trials Market

34. Recent Developments In The Artificial Intelligence (AI) In Clinical Trials Market

35. Artificial Intelligence (AI) In Clinical Trials Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Countries Offering Most New Opportunities

35.2 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Segments Offering Most New Opportunities

35.3 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Medable Inc. Financial Performance
  • Table 78: PathAI inc. Financial Performance
  • Table 79: Saama Technologies Inc. Financial Performance
  • Table 80: TriNetX LLC Financial Performance
  • Table 81: SymphonyAI Summit Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Medable Inc. Financial Performance
  • Figure 78: PathAI inc. Financial Performance
  • Figure 79: Saama Technologies Inc. Financial Performance
  • Figure 80: TriNetX LLC Financial Performance
  • Figure 81: SymphonyAI Summit Inc. Financial Performance

Frequently Asked Questions

Artificial intelligence in clinical trials refers to using artificial intelligence to design more efficient and adequate clinical trials. Artificial intelligence is used in clinical trials to improve trial design and optimization through predictions about patient behavior and drug efficacy. For further insights on this market, request a sample here

The market major growth driver - Ai's Crucial Role In Reducing Clinical Trial Expenditure Fuels The Artificial Intelligence In The Clinical Trial Market Growth. For further insights on this market, request a sample here

The artificial intelligence (ai) in clinical trials market size has grown exponentially in recent years. It will grow from $7.19 billion in 2024 to $10.11 billion in 2025 at a compound annual growth rate (CAGR) of 40.6%. The growth in the historic period can be attributed to increasing data complexity, rising costs and time constraints, regulatory demands, early ai applications, patient-centric approaches. The artificial intelligence (ai) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $36.12 billion in 2029 at a compound annual growth rate (CAGR) of 37.5%. The growth in the forecast period can be attributed to personalized medicine emphasis, real-time monitoring solutions, remote trial execution, risk prediction and mitigation, expanded data sources integration. Major trends in the forecast period include adaptive trial design, natural language processing (NLP) in data analysis, ai-driven patient recruitment, blockchain integration for data security, predictive analytics for patient outcomes. For further insights on this market, request a sample here

The artificial intelligence (ai) in clinical trialsmarket covered in this report is segmented –
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Application: Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users Subsegments:
1) By Software: AI-driven Analytics Platforms, Data Management Tools, Patient Recruitment Solutions, Predictive Modeling Software
2) By Services: Consulting Services, Data Annotation And Labeling Services, Custom AI Model Development, Implementation And Integration Services For further insights on this market,
request a sample here

North America was the largest region in the artificial intelligence (AI) in clinical trials market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the artificial intelligence (AI) in clinical trials market include Medable Inc., PathAI inc., Saama Technologies Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Products Reshapes The Artificial Intelligence In The Clinical Trial Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon